The company's financial position is weakening, with total assets contracting from $72.0 million in 2024Q4 to $57.5 million in 2026Q1, despite maintaining a low debt-to-equity ratio of 0.01.
| Total Current Assets | 12.75M | 18.12M | 23.6M | 9.02M | 6.07M | 0 | 0 |
| Cash & Short-Term Investments | - | - | - | - | - | - | - |
| Cash Only | - | - | - | - | - | - | - |
| Short-Term Investments | - | - | - | - | - | - | - |
| Accounts Receivable | - | - | - | - | - | - | - |
| Days Sales Outstanding | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - |
| Days Inventory Outstanding | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 4.76M | 3.09M | 2.03M | 309.82K | -6.69M | -12.63M |
| Total Non-Current Assets | 44.72M | 45.62M | 48.38M | 33.96M | 19.63M | 0 | 0 |
| Property, Plant & Equipment | 703K | 664K | 731.85K | 3.19M | 2.03M | 1.3M | 215.16K |
| Fixed Asset Turnover | 7.72x | 6.45x | 3.03x | 1.33x | 0.55x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 163.68M | 40.35M | 44.29M | 27.46M | 17.23M | 0 | 0 |
| Other Non-Current Assets | - | - | - | - | - | - | - |
| Total Assets | 57.46M | 63.74M | 71.98M | 42.99M | 25.7M | 8.25M | 27.94M |
| Asset Turnover | 0.09x | 0.07x | 0.03x | 0.10x | 0.04x | - | - |
| Asset Growth % | 120.55% | -11.44% | 67.44% | 67.25% | 211.55% | -70.47% | - |
| Total Current Liabilities | 348K | 2.55M | 1.19M | 3.25M | 1.17M | 0 | 0 |
| Accounts Payable | 348K | 2.46M | 1.1M | 578.21K | 698.78K | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - |
| Short-Term Debt | 581K | 0 | 0 | 0 | 0 | 720.63K | 251.34K |
| Deferred Revenue (Current) | 0 | - | - | - | - | - | - |
| Other Current Liabilities | -581K | 0 | 0 | 0 | 0 | -720.63K | -251.34K |
| Current Ratio | 36.63x | 7.10x | 19.80x | 2.78x | 5.20x | - | - |
| Quick Ratio | 36.63x | 7.10x | 19.80x | 2.78x | 5.20x | - | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 891K | 609K | 711.5K | 2.42M | 1.42M | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | - | - | - | - | - | - |
| Deferred Tax Liabilities | 0 | - | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - | - | - |
| Total Liabilities | 1.24M | 3.16M | 1.9M | 5.67M | 2.59M | 1.49M | 3.33M |
| Total Debt | 581K | 609K | 711.5K | 2.42M | 1.42M | 720.63K | 251.34K |
| Net Debt | -11.95M | -12.61M | -19.73M | -3.69M | -3.53M | -5.5M | -12.23M |
| Debt / Equity | 0.01x | 0.01x | 0.01x | 0.06x | 0.06x | 0.11x | 0.01x |
| Debt / EBITDA | -0.03x | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.61x | - | - | - | - | - | - |
| Interest Coverage | - | - | 168.87x | - | - | - | - |
| Total Equity | 56.22M | 60.58M | 70.07M | 37.32M | 23.11M | 6.76M | 24.61M |
| Equity Growth % | 171.75% | -13.55% | 87.76% | 61.5% | 241.78% | -72.53% | - |
| Book Value per Share | 5.49 | 6.04 | 15.84 | 4.61 | 2.73 | 0.80 | 2.91 |
| Total Shareholders' Equity | 56.34M | 60.69M | 70.16M | 37.31M | 22.64M | 6.24M | 24.67M |
| Common Stock | 0 | 80.49M | 68.72M | 0 | 27.76M | 0 | 0 |
| Retained Earnings | -26.54M | -19.8M | 1.44M | -12.09M | -5.12M | 0 | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 6.24M | 24.67M |
| Minority Interest | -112K | -111K | -89.67K | 7.25K | 468.67K | 522.17K | -53.17K |
Persistent cash burn depletion
According to quarterly balance sheet data, MDBH's total assets have declined from a peak of $72.0 million in 2024Q4 to $57.5 million by 2026Q1, reflecting a consistent contraction that mirrors the firm's inability to generate sustainable internal capital to offset its ongoing operational deficits.
The downward trend in total assets suggests that the company is consuming its capital base to fund its dual-track business model. Investors should monitor whether this trajectory indicates a structural shrinking of the firm's capacity to support its incubator activities without further dilutive financing.
As reported in financial statements, MDBH's cash position has steadily eroded from $20.4 million in 2024Q4 to $12.5 million in 2026Q1, signaling a tightening liquidity buffer that may limit the firm's flexibility to pursue long-term synthetic biology research without securing additional external capital.
While the current ratio remains elevated, this metric is likely distorted by the composition of current assets and does not fully capture the urgency of the firm's cash burn. The consistent decline in cash reserves warrants investigation into the company's ability to sustain its current operating model over the next several quarters.
Based on reported figures, MDBH's retained earnings have deteriorated significantly, moving from a positive $1.4 million in 2024Q4 to a deficit of $26.5 million by 2026Q1, which highlights the substantial cumulative impact of the firm's persistent operating losses on shareholder equity quality.
The rapid shift into negative retained earnings suggests that the company's strategic pivot has been value-destructive to date. This trend implies that the firm's equity base is increasingly reliant on capital infusions rather than organic growth, which may pose risks to long-term shareholder value.
As evidenced by the balance sheet, the absence of goodwill and minimal PPE suggest that MDBH's asset base is primarily liquid, yet the $57.5 million in total assets may be misleading if the underlying intellectual property holdings lack immediate marketability or verifiable fair value.
The lack of tangible asset backing for the firm's valuation implies that the market is pricing the company based on speculative future outcomes rather than current balance sheet strength. Investors should remain cautious, as the firm's reliance on subjective IP valuations could lead to significant impairments if commercialization efforts fail.
Quick answers to the most common questions about buying MDBH stock.
As of 2025, MDB Capital Holdings, LLC Class A common (MDBH) had total assets of $63.7M including $18.1M in current assets.
MDB Capital Holdings, LLC Class A common (MDBH) carries total debt of $0.6M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
MDB Capital Holdings, LLC Class A common (MDBH) has total shareholders' equity (book value) of $60.7M ($6.04 book value per share). Book value represents the net worth of the company belonging to common stock holders.
MDB Capital Holdings, LLC Class A common (MDBH) reported a current ratio of 7.10x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.